Sobhana Babu Boga;Corey Bienstock;Gerald W. Shipps, JR.;Alan B. Cooper;Sie-Mun Lo;Liang Zhu;J;Joseph M. Kelly;Hugh Y. Zhu;Yongqi Deng;Xin Yao;Abdul-Basit Alhassan;Binyuan Sun;Xiaohua Huang;Xiaolei Gao
发明人:
Yongqi Deng,Liang Zhu,Gerald W. Shipps, JR.,Sie-Mun Lo,Binyuan Sun,Xiaohua Huang,Corey Bienstock,Alan B. Cooper,Xiaolei Gao,Xin Yao,Hugh Y. Zhu,Joseph M. Kelly,Sobhana Babu Boga,Abdul-Basit Alhassan,J
申请号：
US13703250
公开号：
US20130096084A1
申请日:
2011.06.22
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention provides a compound of the Formula I: (Formular I should be inserted here) or a pharmaceutically acceptable salt, solvate or ester thereof, wherein R, R1, R2 and R3 are as defined herein. The compounds are ERK inhibitors. Also disclosed are pharmaceutical compositions comprising the above compounds and methods of treating cancer using the same.
